Kayaku to ‘Significantly’ Grow HPAPI Capacity

Nippon Kayaku (Tokyo) says it plans to increase significantly manufacturing capacity for high-potency active pharma ingredients (HPAPI), as part of plans to expand its offering in contract manufacturing and focus on niche technologies. The company says it plans to start building a HPAPI plant at Takasaki, Japan, with a capacity of several hundred kilograms, during the fiscal year ending April 1, 2008. The facility would produce containment level 4 HPAPIs. That plant is in addition to a smaller HPAPI facility that Kayaku is building at Takasaki for completion next...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers